Portage Biotech Stock Price History
| PRTG Stock | USD 4.20 0.05 1.18% |
Below is the normalized historical share price chart for Portage Biotech extending back to July 27, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Portage Biotech stands at 4.20, as last reported on the 19th of March, with the highest price reaching 4.33 and the lowest price hitting 4.16 during the day.
If you're considering investing in Portage Stock, it is important to understand the factors that can impact its price. Portage Biotech maintains Sharpe Ratio (i.e., Efficiency) of -0.0764, which implies the firm had a -0.0764 % return per unit of risk over the last 3 months. Portage Biotech exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Portage Biotech's Risk Adjusted Performance of 0.0676, semi deviation of 6.65, and Coefficient Of Variation of 1517.98 to confirm the risk estimate we provide.
At this time, Portage Biotech's Stock Based Compensation is most likely to increase significantly in the upcoming years. The Portage Biotech's current Issuance Of Capital Stock is estimated to increase to about 9.9 M, while Liabilities And Stockholders Equity is projected to decrease to roughly 8.5 M. . At this time, Portage Biotech's Price To Book Ratio is most likely to decrease significantly in the upcoming years. The Portage Biotech's current Price Sales Ratio is estimated to increase to 2,748, while Price Earnings To Growth Ratio is projected to decrease to 0.08. Portage Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of February 2021 | 200 Day MA 4.7291 | 50 Day MA 4.4429 | Beta 1.608 |
Portage |
Sharpe Ratio = -0.0764
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PRTG |
Estimated Market Risk
| 5.4 actual daily | 48 52% of assets are more volatile |
Expected Return
| -0.41 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Portage Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Portage Biotech by adding Portage Biotech to a well-diversified portfolio.
Portage Biotech Stock Price History Chart
There are several ways to analyze Portage Stock price data. The simplest method is using a basic Portage candlestick price chart, which shows Portage Biotech price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 18, 2024 | 7.9 |
| Lowest Price | January 16, 2025 | 3.96 |
Portage Biotech March 19, 2025 Stock Price Synopsis
Various analyses of Portage Biotech's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Portage Stock. It can be used to describe the percentage change in the price of Portage Biotech from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Portage Stock.| Portage Biotech Price Action Indicator | (0.07) | |
| Portage Biotech Accumulation Distribution | 147.27 | |
| Portage Biotech Price Daily Balance Of Power | (0.29) | |
| Portage Biotech Price Rate Of Daily Change | 0.99 |
Portage Biotech March 19, 2025 Stock Price Analysis
Portage Stock Price History Data
The price series of Portage Biotech for the period between Thu, Dec 19, 2024 and Wed, Mar 19, 2025 has a statistical range of 6.04 with a coefficient of variation of 18.89. The price distribution for the period has arithmetic mean of 4.63. The median price for the last 90 days is 4.45. The company completed stock split (1:20) on 15th of August 2024. Portage Biotech had dividends distributed to its stock-holders on 2020-06-04.| Open | High | Low | Close | Volume | ||
| 03/19/2025 | 4.16 | 4.33 | 4.16 | 4.20 | 3,751 | |
| 03/18/2025 | 4.26 | 4.30 | 4.20 | 4.20 | 9,530 | |
| 03/17/2025 | 4.39 | 4.39 | 4.24 | 4.25 | 3,921 | |
| 03/14/2025 | 4.30 | 4.49 | 4.04 | 4.21 | 21,785 | |
| 03/13/2025 | 4.03 | 4.43 | 4.03 | 4.04 | 25,176 | |
| 03/12/2025 | 4.02 | 4.24 | 4.02 | 4.05 | 24,132 | |
| 03/11/2025 | 4.01 | 4.27 | 3.92 | 4.17 | 24,007 | |
| 03/10/2025 | 4.23 | 4.39 | 4.00 | 4.00 | 7,500 | |
| 03/07/2025 | 4.25 | 4.45 | 4.20 | 4.45 | 5,938 | |
| 03/06/2025 | 4.11 | 4.45 | 4.11 | 4.40 | 4,218 | |
| 03/05/2025 | 4.30 | 4.48 | 4.29 | 4.40 | 26,800 | |
| 03/04/2025 | 3.97 | 4.34 | 3.92 | 4.25 | 23,774 | |
| 03/03/2025 | 4.49 | 4.52 | 4.13 | 4.14 | 7,209 | |
| 02/28/2025 | 4.41 | 4.70 | 4.36 | 4.51 | 16,059 | |
| 02/27/2025 | 4.50 | 4.92 | 4.15 | 4.34 | 52,126 | |
| 02/26/2025 | 4.30 | 4.50 | 4.20 | 4.50 | 4,815 | |
| 02/25/2025 | 4.63 | 4.63 | 4.31 | 4.31 | 3,828 | |
| 02/24/2025 | 4.59 | 4.98 | 4.41 | 4.60 | 10,877 | |
| 02/21/2025 | 4.65 | 5.00 | 4.51 | 4.57 | 6,494 | |
| 02/20/2025 | 4.52 | 4.96 | 4.46 | 4.69 | 57,401 | |
| 02/19/2025 | 4.64 | 5.00 | 4.51 | 4.65 | 53,069 | |
| 02/18/2025 | 4.73 | 4.80 | 4.52 | 4.78 | 16,160 | |
| 02/14/2025 | 4.62 | 4.82 | 4.39 | 4.70 | 7,787 | |
| 02/13/2025 | 4.87 | 4.92 | 4.64 | 4.84 | 7,743 | |
| 02/12/2025 | 4.77 | 5.09 | 4.29 | 4.80 | 13,730 | |
| 02/11/2025 | 4.62 | 5.34 | 4.62 | 5.04 | 32,948 | |
| 02/10/2025 | 4.60 | 5.12 | 4.40 | 4.76 | 93,076 | |
| 02/07/2025 | 4.97 | 5.24 | 4.60 | 4.71 | 49,680 | |
| 02/06/2025 | 4.14 | 5.30 | 4.14 | 5.23 | 80,612 | |
| 02/05/2025 | 4.27 | 4.48 | 4.15 | 4.27 | 24,973 | |
| 02/04/2025 | 4.27 | 4.50 | 3.87 | 4.45 | 82,404 | |
| 02/03/2025 | 4.40 | 4.92 | 3.80 | 4.50 | 548,372 | |
| 01/31/2025 | 4.56 | 4.70 | 4.21 | 4.41 | 1,103,414 | |
| 01/30/2025 | 4.30 | 5.50 | 3.86 | 4.56 | 219,332 | |
| 01/29/2025 | 4.61 | 4.71 | 4.26 | 4.43 | 12,989 | |
| 01/28/2025 | 3.99 | 4.98 | 3.91 | 4.70 | 71,120 | |
| 01/27/2025 | 4.30 | 4.59 | 4.08 | 4.11 | 47,819 | |
| 01/24/2025 | 4.01 | 4.62 | 4.01 | 4.20 | 67,267 | |
| 01/23/2025 | 4.06 | 4.15 | 3.77 | 4.00 | 20,010 | |
| 01/22/2025 | 4.11 | 4.15 | 4.01 | 4.10 | 5,128 | |
| 01/21/2025 | 4.10 | 4.27 | 4.05 | 4.11 | 45,650 | |
| 01/17/2025 | 4.05 | 4.40 | 3.99 | 4.10 | 164,096 | |
| 01/16/2025 | 3.99 | 4.15 | 3.86 | 3.96 | 13,120 | |
| 01/15/2025 | 4.16 | 4.27 | 3.86 | 3.97 | 26,776 | |
| 01/14/2025 | 4.18 | 4.57 | 4.01 | 4.21 | 10,252 | |
| 01/13/2025 | 4.28 | 4.60 | 4.20 | 4.27 | 13,745 | |
| 01/10/2025 | 4.62 | 4.98 | 4.30 | 4.37 | 27,354 | |
| 01/08/2025 | 4.89 | 4.95 | 4.43 | 4.71 | 30,942 | |
| 01/07/2025 | 5.28 | 5.28 | 4.85 | 4.99 | 21,365 | |
| 01/06/2025 | 4.99 | 5.84 | 4.72 | 5.15 | 200,757 | |
| 01/03/2025 | 4.85 | 4.99 | 4.68 | 4.98 | 40,724 | |
| 01/02/2025 | 5.07 | 5.20 | 4.77 | 4.88 | 57,347 | |
| 12/31/2024 | 5.33 | 5.86 | 5.03 | 5.17 | 35,129 | |
| 12/30/2024 | 5.15 | 5.53 | 5.09 | 5.14 | 28,643 | |
| 12/27/2024 | 5.51 | 5.98 | 5.22 | 5.26 | 110,071 | |
| 12/26/2024 | 4.83 | 5.91 | 4.83 | 5.59 | 135,084 | |
| 12/24/2024 | 5.43 | 5.43 | 4.63 | 5.19 | 99,494 | |
| 12/23/2024 | 6.00 | 6.15 | 5.26 | 5.39 | 175,731 | |
| 12/20/2024 | 5.40 | 6.34 | 5.40 | 5.96 | 60,489 | |
| 12/19/2024 | 7.53 | 7.59 | 5.35 | 5.85 | 193,548 | |
| 12/18/2024 | 8.89 | 9.83 | 7.30 | 7.90 | 1,116,117 |
About Portage Biotech Stock history
Portage Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Portage is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Portage Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Portage Biotech stock prices may prove useful in developing a viable investing in Portage Biotech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 23.4 M | 24.6 M | |
| Net Loss | -15.2 M | -14.4 M |
Portage Biotech Quarterly Net Working Capital |
|
Portage Biotech Stock Technical Analysis
Portage Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Portage Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Portage Biotech's price direction in advance. Along with the technical and fundamental analysis of Portage Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Portage to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0676 | |||
| Jensen Alpha | 0.6994 | |||
| Total Risk Alpha | 4.05 | |||
| Sortino Ratio | 0.207 | |||
| Treynor Ratio | (0.18) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Portage Stock analysis
When running Portage Biotech's price analysis, check to measure Portage Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Portage Biotech is operating at the current time. Most of Portage Biotech's value examination focuses on studying past and present price action to predict the probability of Portage Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Portage Biotech's price. Additionally, you may evaluate how the addition of Portage Biotech to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |